Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: GENENTECH USA, INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2025-01-30 to 2027-01-29
Current total value of award: $45106864
Description: OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES